Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 and Phase 2a Clinical Trial:Immunization of Human Volunteers With P. Vivax Irradiated Sporozoites

NCT01082341 is registered in ClinicalTrials.gov with Malaria Vaccine and Drug Development Center as lead sponsor.

NCT NCT01082341
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01082341 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 and Phase 2a Clinical Trial:Immunization of Human Volunteers With P. Vivax Irradiated Sporozoites
Lead sponsor
Malaria Vaccine and Drug Development Center
Phase
Phase 1/2
Overall status
Completed
Start date
June 30, 2012
Completion date
September 30, 2017
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria